Medical Facilities Corporation
MFCSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $332 | $446 | $425 | $399 |
| % Growth | -25.6% | 5% | 6.5% | – |
| Cost of Goods Sold | $112 | $283 | $144 | $130 |
| Gross Profit | $220 | $163 | $281 | $269 |
| % Margin | 66.3% | 36.5% | 66.1% | 67.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $151 | $74 | $198 | $178 |
| SG&A Expenses | $151 | $75 | $198 | $178 |
| Sales & Mktg Exp. | $0 | $1 | $0 | $0 |
| Other Operating Expenses | $7 | $20 | $31 | $14 |
| Operating Expenses | $158 | $96 | $229 | $191 |
| Operating Income | $62 | $67 | $47 | $77 |
| % Margin | 18.6% | 15.1% | 11.1% | 19.4% |
| Other Income/Exp. Net | -$11 | -$15 | -$17 | -$26 |
| Pre-Tax Income | $51 | $52 | $18 | $51 |
| Tax Expense | -$6 | $8 | $5 | $4 |
| Net Income | $73 | $19 | $12 | $46 |
| % Margin | 22.2% | 4.2% | 2.9% | 11.7% |
| EPS | 3.06 | 0.73 | 0.42 | 1.5 |
| % Growth | 319.2% | 73.8% | -72% | – |
| EPS Diluted | 3.06 | 0.73 | 0.42 | 1.49 |
| Weighted Avg Shares Out | 24 | 25 | 29 | 31 |
| Weighted Avg Shares Out Dil | 24 | 25 | 29 | 31 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $0 | $9 | $0 |
| Interest Expense | $4 | $17 | $13 | $6 |
| Depreciation & Amortization | $19 | $11 | $20 | $27 |
| EBITDA | $83 | $78 | $43 | $103 |
| % Margin | 24.9% | 17.5% | 10.2% | 25.9% |